Yüklüyor......
The Antipsoriatic Agent Monomethylfumarate Has Antiproliferative, Prodifferentiative, and Anti-Inflammatory Effects on Keratinocytes
Monomethylfumarate (MMF) is thought to be the bioactive ingredient of the drug Fumaderm (Biogen Idec, Cambridge, MA), licensed in Germany since 1994 for the treatment of moderate-to-severe psoriasis. Psoriasis is a common inflammatory hyperproliferative skin disorder that involves cross-talk between...
Kaydedildi:
| Yayımlandı: | J Pharmacol Exp Ther |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4279100/ https://ncbi.nlm.nih.gov/pubmed/25332455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.218818 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|